Delaware is the US’s go-to venue for pharma patent litigation, but there could be trouble ahead
Reset password
Register to access two of our subscriber only articles per month.
Register
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
Subscribe
Author | Life sciences reporter
[email protected]
@IAM_magazine In its big-ticket licensing fight with Ericsson, Samsung has filed its first challenges at the PTAB but its move sh… https://t.co/6EMSSfyDgh Read more
@IAM_magazine Allergan’s Botox trade secrets win at the ITC win underlines the commission's growing importance in life sciences I… https://t.co/1zjhfn9Ebf Read more
@IAM_magazine Once a rising supply chain star and a big patent buyer, now a Chinese company that landed on the Entity List is mov… https://t.co/qDQbTl4jnr Read more
@IAM_magazine Austin's recent growth as a tech powerhouse has also seen it emerge as a significant IP hub https://t.co/1ABS4ayhje https://t.co/DPgVZmocGv Read more
